IP Library Granted Patent US 8,338,132
Granted Patent B2
US 8,338,132 · App. 12/412,796 · Granted Dec 25, 2012

Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,338,132
App. No.
12/412,796
Granted
Dec 25, 2012
Kind
B2
Abstract

The present invention is directed to novel polypeptides having sequence identity with IL-17, IL-17 receptors and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Claims (12)

1. An isolated nucleic acid comprising a nucleic acid sequence having at least 99% nucleic acid sequence identity to:

(a) the nucleic acid sequence of SEQ ID NO:13;

(b) the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:13; or

(c) the full-length coding sequence of the cDNA deposited under ATCC accession number PTA-1535,

wherein said isolated nucleic acid encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14.

2. The isolated nucleic acid of claim 1 comprising a nucleic acid sequence having at least 99% nucleic acid sequence identity to the nucleic acid sequence of SEQ ID NO:13, wherein said isolated nucleic acid encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14.

3. The isolated nucleic acid of claim 1 comprising a nucleic acid sequence having at least 99% nucleic acid sequence identity to the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:13, wherein said isolated nucleic acid encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14.

4. The isolated nucleic acid of claim 1 comprising a nucleic acid sequence having at least 99% nucleic acid sequence identity to the full-length coding sequence of the cDNA deposited under ATCC accession number PTA-1535, wherein said isolated nucleic acid encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14.

5. A vector comprising the nucleic acid of claim 1 .

6. The vector of claim 5 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.

7. An isolated host cell comprising the vector of claim 5 .

8. The host cell of claim 7 wherein said cell is a CHO cell, an E. coli or a yeast cell.